Dr. André Bachmann, Professor of Pediatrics at Michigan State University and a collaborator with Genawif, has been honoured with the 2023 NYIPLA “Inventor of the Year Award” for US Patent No. 11,273,137 B2. The New York Property Law Association makes its award annually. The Patent describes the re-purposing of the FDA-approved drug difluoromethylornithine for the treatment of a rare genetic disorder called Bachmann-Bupp Syndrome. The award is shared by Dr. Bachmann, Dr Bupp and Dr. Rajasekaran and will be presented on 10th May in New York.
Renommierte Auszeichnung für Genawif-Kooperationspartner Dr. André Bachmann